Tradestie Institutional Equity Comparison Engine
XZO vs LMRI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XZO Overall Edge
XZO Captures Institutional Edge (2โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Exzeo Group, Inc. (XZO) driven by superior Valuation, Growth & Margin while LMRI counters with relative strength in Momentum & Technical. Fundamentally, XZO trades at 12.5x Forward P/E with 50.4% operating margin (+4.0% YoY revenue) versus LMRI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XZO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LMRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
XZO
XZO 12.5x vs LMRI N/M Fwd P/E
Growth & Margin Winner
XZO
Op Margin 50.4% vs N/A ยท YoY +4.0% vs N/A
Momentum & Technical Winner
LMRI
1Y +0.9% vs -23.0% ยท 52W Pos 19% vs 60%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
XZO
US Equity
Exzeo Group, Inc.
Services-Prepackaged Software
$14.72
-3.03% 1D
Market Cap
$1.4B
1M Return
-13.41%
1Y Return
+0.89%
Forward P/E
12.5x
Unified AI Score
47.7 / 100
HOLD
Tech 39.0
Fund 50.0
Flow 50.0
Mom 60.0
LMRI
US Equity
LMRI
Institutional Equity
$14.26
+1.42% 1D
Market Cap
N/A
1M Return
+30.95%
1Y Return
-23.0%
Forward P/E
N/M
Unified AI Score
32.1 / 100
SELL
Tech 50.0
Fund 30.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XZO +0.89%
LMRI -23.0%
Spread: +3.18 pp (LMRI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XZO TTM Op. Margin: 50.4%
LMRI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XZO vs LMRI. Trailing 12-month operating profitability (XZO 50.4% vs LMRI N/A) and valuation multiples (XZO 12.5x vs LMRI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XZO | LMRI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.4B | N/A | Larger Scale | XZO |
| Trailing P/E Ratio Valuation | 15.5x | N/M | Lower Multiple | XZO |
| Forward P/E Ratio Valuation | 12.5x | N/M | Lower Multiple | XZO |
| Revenue Growth (YoY) Growth | +4.0% | N/A | Higher Growth | XZO |
| Operating Margin (TTM) Profitability | 50.4% | N/A | Higher Margin | XZO |
| Net Profit Margin Profitability | 37.8% | N/A | Higher Margin | XZO |
| Return on Equity (ROE) Capital Efficiency | 46.7% | N/A | Higher ROE | XZO |
| 52-Week Range Position Momentum | 19% ($12โ$25) | 60% ($6โ$19) | Stronger Trend | LMRI |
| Beta / 30D Volatility Risk Regime | 1.08ฮฒ ยท 60% Vol | 1.22ฮฒ ยท 85% Vol | Lower Realized Risk | XZO |
| Unified Institutional Score Composite Signal | 47.7 / 100 (HOLD) | 32.1 / 100 (SELL) | Higher Composite | XZO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XZO vs LMRI Buy Guide
XZO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
LMRI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XZO nor LMRI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.